CGT Industry Upgrade Series Tour - Stop 8: Shenzhen Weiguang Life Science Park & Bay Gravity
Event Information
■ Stop 8: Shenzhen Weiguang Life Science Park & Bay Gravity
Event Time: 13:00, Thursday, April 25, 2024
Event Venue: 8th Floor, Building 1B, Weiguang Life Science Park, Guangming District, Shenzhen Bay Gravity (Guangming Biomedical Innovation Center)
Host OrganizationHealthcare Innovative Ecosystem Alliance (HIEA)
Co-Hosted by: Hangcheng Biotech, Yeasen Biotechnology, Lepu Biopharma, Vigene Biosciences, Danaher Life Sciences, Shenyen Biotech, Lingfu Top Biotech, Hanhuang Technology, Legend Capital
Organizer: Arterial New Medicine
Co-organizers: Weiguang Life Science Park, Times High-Tech, Bay Gravity (Guangming Biomedical Innovation Center)
Since November 2023, VBInsight, in collaboration with enterprises across the cell and gene therapy (CGT) industry chain, has held seven events as part of its “CGT Industry Upgrade Park Tour” series. These events took place in Shanghai Zhangjiang, Shanghai Free Trade Zone No. 1, Nanjing Bio-Medicine Valley, Suzhou BioBAY, Beijing New Nest Innovation Center, Beijing Yichuang Gaoke Innovation Technology Park, and Guangzhou International Business Incubator. The series brought together decision-making elites from numerous CGT innovators and service providers across the industry chain, creating a platform for open dialogue and authentic exchange. The initiative aims to deepen communication and cooperation among all parties, jointly develop high-quality CGT products, and promote the coordinated development of the entire industry chain.
Amid the ongoing capital winter, strengthening CMC, exploring financing options, pursuing international expansion, and maintaining operational viability have become core strategic imperatives that innovative pharmaceutical companies must urgently address.
Based on this, byOrganized by the Healthcare Innovative Ecosystem Alliance (HIEA); co-organized by Hangcheng Biotechnology, Yeasen Biotechnology, Lepu Biotechnology, VectorBuilder, Danaher Life Sciences, Shenzhen Genomics Institute, Lingfu Top Biotechnology, Hanhuang Technology, and Legend Capital; supported by Weiguang Life Science Park, Times High-Tech, and Bay Gravity (Guangming Biomedical Innovation Center); undertaken by VCBeat New Medicine.of“[No Need to Compete, Go Further] CGT Industry Upgrade Series · Park Tour Stop 8” will be held on April 25 (Thursday) at Shenzhen Weiguang Life Science Park & Bay Gravity.
Shenzhen Weiguang Life Science Park: Actual View:
Wan You Yinli Real Scene:
Share Highlights
CGT from an Investment Perspective: With investor acumen, distill new pathways for capital operations by innovative pharmaceutical companies during discussions on investment and financing strategies in the CGT sector, helping enterprises seize growth opportunities and navigate challenges.
Optimal Supply Chain Solution: Listen to Party A’s needs, and supply chain enterprises will work together to explore the most suitable solutions, striving to help innovative companies transition smoothly, rapidly, and cost-effectively from IND to BLA.
Global Insights · CGT Quality Management: Focusing on the forefront, we delve into comprehensive quality control throughout the cell and gene therapy lifecycle. We uncover the impact of global regulations, analyze successful case studies, and empower enterprises to build efficient, compliant systems, safeguarding the safe delivery of innovative therapies to patients.
[Experts Arrive]: Top industry leaders will be present in person to interpret the quality lifeline of CGT products within a global framework, reveal the essence of quality control at every stage, and jointly chart a blueprint for CGT product quality targeting the global market.
[Translation of Laboratory Achievements]: Scientists, entrepreneurs, investors, and supply chain experts share the stage to discuss collaborative strategies for bridging the “Valley of Death” between laboratory breakthroughs and industrialization.
[Addressing Hot Topics]: Amidst the economic downturn and intensifying global competition, how can cell and gene therapy (CGT) companies defy the odds during the capital winter to rival “Mr. 300 Million”? Furthermore, how should they collaborate with supply chain partners to safely expand overseas and pioneer new blue-ocean markets internationally?
Shenzhen Weiguang Life Science Park——As a key engine for the CGT industry in South China, it is China’s first specialized biomedical industrial park distinguished by the commercialization of “synthetic biology” achievements. Its prominent innovative vitality and pragmatic spirit of industrial cooperation have provided a solid foundation for innovation in the CGT sector.
Bay Gravity——Co-established by the Guangming District Government and Shenzhen Bay Laboratory, it focuses on original innovation projects, fully supports scientists and physicians in their entrepreneurial and innovative endeavors, provides a one-stop acceleration experience, and empowers biopharmaceutical startups to grow from inception to realize their innovative value.
The “Shenzhen Weiguang Life Science Park & Bay Area Gravity” event marks the eighth stop in the park tour series. Similar events will be held in other parks in the future to promote the continuous upgrading and development of the CGT industry. We look forward to engaging in discussions and making progress together with industry peers, helping the CGT industry go further!
Event Agenda
■ 13:00–13:30 Visit to Weiguang Life Science Park, Shenzhen Medical Academy of Research and Translation, and Bay Gravity (Guangming Biomedical Innovation Center)
■ 13:30–13:40 Opening Remarks by the Moderator + Address by Park Leadership
Host | Event Expectations and Ecosystem Synergy Support
Park Leadership | Park Introduction and Future Outlook
■ 13：40-14：00
Keynote Speech 1[Experts Arrive]| Quality Management of CGT Products Across the Full Lifecycle from a Global Perspective
Eglin Pharma
■ 14：00-14：20
Keynote Speech 2 |Keynote Address by Co-Organizing Enterprise
Danaher Life Sciences
■ 14：20-14：40
Keynote Speech 3 |Preparation and Evaluation of Animal Disease Models
Lingfu Top Biology
■ 14：40-15：00
Keynote Speech 4 |Co-organized Enterprise Keynote Speech
Hanhuang Technology
■ 15：00-15：50
Panel 1 | How to Partner with CGT Companies to Navigate from IND to BLA: Stable, Fast, and Cost-Effective?
Introduction to Core Competencies and Service Value
How to Engage Constructively with Clients and Foster Mutual Support in a Professional Setting
■ 15:50–16:10 Tea Break
■ 16：10-17：00
Panel 2[Site Features]| Discussing the Translation of Scientific Research Achievements: How Should All Parties Collaborate and Coordinate in Moving from the Laboratory to Industrialization?
Difficulties and Challenges in the Translation of Frontier Achievements
Stakeholders' Focus Areas and Collaboration in the Commercialization of Scientific Achievements
How to Break Through the Bottleneck of Technology Maturation
■ 17：00-17：20
Keynote Speech 5 |CGT Industry Progress and Trends from an Investment Perspective
Finance as a Tool: Understanding Capital Market Trends
Industry as the Foundation: Current Status and Outlook of the CGT Sector
Legend Capital
■ 17：20-18：00
Panel 3[Hot Topics Included]| Under the New Landscape, How Can CGT Companies Effectively “Raise and Spend Capital”?
Hot Topic 1: The 300 Million Yuan Man in the Winter
Hot Topic 2: How R&D and Supply Chain Enterprises Can “Safely” Go Global
■ 18:30–20:30 Dinner Reception (Invitation Only)
Event Scale: 50 attendees/session
Event Partnerships:
Ms. Fu 17851017836 (WeChat ID same as phone number)
Event Registration:
Capillaries 17782369627 (WeChat ID same)
Previous Reviews